Caseware UK (AP4) 2024.0.164 2024.0.164 2024-03-312024-03-31false12023-04-011falseLocum pharmasisttruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06865233 2023-04-01 2024-03-31 06865233 2022-04-01 2023-03-31 06865233 2024-03-31 06865233 2023-03-31 06865233 c:Director1 2023-04-01 2024-03-31 06865233 d:CurrentFinancialInstruments 2024-03-31 06865233 d:CurrentFinancialInstruments 2023-03-31 06865233 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 06865233 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 06865233 d:ShareCapital 2024-03-31 06865233 d:ShareCapital 2023-03-31 06865233 d:RetainedEarningsAccumulatedLosses 2024-03-31 06865233 d:RetainedEarningsAccumulatedLosses 2023-03-31 06865233 c:FRS102 2023-04-01 2024-03-31 06865233 c:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 06865233 c:FullAccounts 2023-04-01 2024-03-31 06865233 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06865233 2 2023-04-01 2024-03-31 06865233 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 06865233










AMB MEDS LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
AMB MEDS LTD
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OFAMB MEDS LTD
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of AMB Meds Ltd for the year ended 31 March 2024 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

This report is made solely to the director of AMB Meds Ltd in accordance with the terms of our agreement. Our work has been undertaken solely to prepare for your approval the financial statements of AMB Meds Ltd and state those matters that we have agreed to state to him in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than AMB Meds Ltd and its  director for our work or for this report.
 
 
It is your duty to ensure that AMB Meds Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the Company's assets, liabilities, financial position and loss. You consider that AMB Meds Ltd is exempt from the statutory audit requirement for the year.
 
 
We have not been instructed to carry out an audit or review of the financial statements of AMB Meds Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.







Shipleys Tax Planning

24 March 2025
Page 1

 
AMB MEDS LTD
REGISTERED NUMBER: 06865233

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
258
258

Cash at bank and in hand
 5 
6,185
7,136

  
6,443
7,394

Creditors: amounts falling due within one year
 6 
(4,617)
(4,041)

Net current assets
  
 
 
1,826
 
 
3,353

Total assets less current liabilities
  
1,826
3,353

  

Net assets
  
1,826
3,353


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
1,726
3,253

  
1,826
3,353


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 March 2025.






Alexander Torpy
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
AMB MEDS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

AMB Meds Ltd is a company domiciled in England & Wales, registration number 06865233. The registered office is 9 Willow Tree Way, Moulton, Northampton, NN3 7BW.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 3

 
AMB MEDS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
AMB MEDS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).


4.


Debtors

2024
2023
£
£


Other debtors
258
258

258
258



5.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
6,185
7,136

6,185
7,136



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
68
68

Other creditors
3,829
3,073

Accruals and deferred income
720
900

4,617
4,041



7.


Related party transactions

There were no related party transactions during the year.


Page 5